Mustafa D.
- Country
- Germany
- Department
- Women's Clinic
Research Overview
- A Phase III, Randomized, Double-blind Study to Evaluate Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy for Triple Negative Breast Cancer (TNBC)
- Study of Inavolisib with Trastuzumab and Pertuzumab as Maintenance Therapy in Patients with HER2‑Positive PIK3CA‑Mutated Locally Advanced or Metastatic Breast Cancer
- Phase 3 Randomized Study of Gedatolisib Combination Therapy versus Standard Endocrine Therapy in HR‑Positive, HER2‑Negative Advanced Breast Cancer Post‑CDK4/6 Inhibitor
Data & Insights
Has run more than one trial at 400 of 712 partner sites.
Specializations
Breast Cancer Research
This investigator specializes in various forms of breast cancer treatment, with particular emphasis on targeted therapies for different molecular subtypes.
- Triple-negative breast cancer therapeutic approaches
- HR+/HER2-negative breast cancer treatment strategies
- HER2-positive early breast cancer management
The research encompasses both early-stage and advanced breast cancer treatments, including neoadjuvant and adjuvant therapeutic approaches.
Gynecologic Oncology
Focus on developing treatments for various gynecologic malignancies, particularly in advanced ovarian cancer and related conditions.
- Epithelial ovarian cancer therapeutics
- Endometrial cancer treatment strategies
- Fallopian tube and peritoneal cancer management
The investigator explores novel therapeutic combinations and maintenance treatments for gynecologic cancers.
Innovative Therapies
Expertise in evaluating cutting-edge therapeutic approaches and novel drug combinations.
- Targeted molecular therapies
- Immunotherapy applications
- Hormone therapy optimization
Research includes evaluation of new therapeutic agents and their combinations for various cancer types.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.